companydata.dkNovo Nordisk Research Center Gladsaxe ApS: Financial statements 2020
CVR: 39119374
Novo Nordisk Research Center Gladsaxe ApS (CVR 39119374) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 10,676,598 and a net result of DKK 3,185,064 compared with DKK 14,426,111 the year before. That is a decrease of 58.3% compared with the year before. Equity amounted to DKK 9,487,231. The solvency ratio was 81.1%. The company had 5 employees in the financial year.
- Gross Profit
- 10,676,598 kr.
- Profit/Loss
- 3,185,064 kr.
- Equity
- 9,487,231 kr.
- Total Assets
- 11,705,013 kr.
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 10.7 mio. | 3.2 mio. | 9.5 mio. | 5 |
| 2019 | - | 25.6 mio. | 14.4 mio. | 18.3 mio. | 5 |
| 2018 | - | 14.9 mio. | 9.8 mio. | 52 t. | 1 |
How creditworthy is Novo Nordisk Research Center Gladsaxe ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Novo Nordisk Research Center Gladsaxe ApS has published its annual report for 2019. Gross profit came to DKK 25,623,833, and the net result was DKK 14,426,111.
About Novo Nordisk Research Center Gladsaxe ApS
Novo Nordisk Research Center Gladsaxe ApS is a Danish company of the type Anpartsselskab based in Bagsværd, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Embark Biotech ApS and Embark Biotech IvS. The management consists of Rikke Ryttergaard Andersen. The company is owned by NOVO NORDISK A/S. The company has 7 employees. In 2025, the company reported a gross profit of DKK -1,000 and a net result of DKK 48,000 compared with DKK 6,174,000 the year before. Equity amounted to DKK 807,000.